The role of PFKFB3 in NAFLD was further demonstrated by the disruption of the myeloid PFKFB3 that resulted in more severe hepatic steatosis and inflammation. This evidence concerns the gene PFKFB3 and metabolic dysfunction-associated steatotic liver disease.